Loading...
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
Antihormonal and chemotherapy are standard treatments for nonorgan-confined prostate cancer. The effectivity of these therapies is limited and the development of alternative approaches is necessary. In the present study, we report on the use of the multikinase inhibitor sorafenib in a panel of prost...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Society for Endocrinology
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3353237/ https://ncbi.nlm.nih.gov/pubmed/22383427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-11-0298 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|